Val
—
Gro
—
Qua
—
Mom
—
Sta
—
Cap—
P/SN/A
P/E—
Fwd P/E23.07
PEG1.64
52W— – —
RSI—
Target$97.65 (+4.4%)
Beta0.32
Div2.24%
Loading chart…
RSI (14)
Loading patterns…
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under the Colgate, Palmolive, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline, and Suavitel brands to a range of traditional and eCommerce retailers, wholesalers, and distributors, as well as dentists and skin health professionals. It also offers pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic pet products to help nutritionally support dogs and cats in different stages of health under the Hill's Prescription Diet brand; and a fresh pet food sold to pet specialty and other retailers in Australia under Prime100 brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.
52-Week Range
52W Low
—
52W High
Position in Range
—
RSI (14)
0 · Oversold
RSI 56
Overbought · 100
Signal
Neutral
EMA Price Levels
Volume Analysis
Momentum Dashboard
Trend Strength
Detected Patterns
3Bullish
0Bearish
0Neutral
▲ Double Bottom — Two lows ~$82.46 — bullish reversal confirmed
▲ Double Bottom — Two lows ~$83.71 — bullish reversal confirmed
▲ Bull Flag — Breakout after +8% pole — bullish continuation
View overlays on the price chart via Chart tab → Pattern Overlays.
EPS — History & Forecast
Estimate
Beat
Miss
Forecast
Loading…
Revenue — History & Forecast
Revenue
Forecast
Loading…
EPS Beat Rate
100%
8/8 quarters
Wall Street Consensus
BUY
BuyHoldSell
Price Target Range
$97.65
+4.4% upside
Low $85
—
High $110
Consensus
Current price
Wall Street Analyst Ratings
| Firm | Rating | Change | Action | Date |
|---|---|---|---|---|
| Barclays | Equal-Weight | — | ↔ Maintain | 2026-07-21 |
| JP Morgan | Overweight | — | ↔ Maintain | 2026-07-16 |
| UBS | Buy | — | ↔ Maintain | 2026-07-16 |
| Citigroup | Buy | — | ↔ Maintain | 2026-07-14 |
| Piper Sandler | Overweight | — | ↔ Maintain | 2026-07-09 |
| Wells Fargo | Equal-Weight | — | ↔ Maintain | 2026-07-08 |
| Bernstein | Market Perform | — | ● Initiate | 2026-06-11 |
| RBC Capital | Outperform | — | ↔ Reiterate | 2026-05-04 |
| Morgan Stanley | Overweight | — | ↔ Maintain | 2026-04-23 |
| Rothschild & Co | Buy | Neutral → Buy | ▲ Upgrade | 2026-04-21 |
| B of A Securities | Buy | — | ↔ Maintain | 2026-04-10 |
| Deutsche Bank | Buy | Hold → Buy | ▲ Upgrade | 2026-03-30 |
| Jefferies | Hold | — | ↔ Maintain | 2026-02-02 |
| Evercore ISI Group | Outperform | — | ↔ Maintain | 2026-02-02 |
| TD Cowen | Buy | — | ↔ Maintain | 2026-01-08 |
| Argus Research | Hold | Buy → Hold | ▼ Downgrade | 2025-12-11 |
Barclays
2026-07-21
Equal-Weight
↔ Maintain
JP Morgan
2026-07-16
Overweight
↔ Maintain
UBS
2026-07-16
Buy
↔ Maintain
Citigroup
2026-07-14
Buy
↔ Maintain
Piper Sandler
2026-07-09
Overweight
↔ Maintain
Wells Fargo
2026-07-08
Equal-Weight
↔ Maintain
Bernstein
2026-06-11
Market Perform
● Initiate
RBC Capital
2026-05-04
Outperform
↔ Reiterate
Morgan Stanley
2026-04-23
Overweight
↔ Maintain
Rothschild & Co
2026-04-21
Buy
(from Neutral)
▲ Upgrade
B of A Securities
2026-04-10
Buy
↔ Maintain
Deutsche Bank
2026-03-30
Buy
(from Hold)
▲ Upgrade
Jefferies
2026-02-02
Hold
↔ Maintain
Evercore ISI Group
2026-02-02
Outperform
↔ Maintain
TD Cowen
2026-01-08
Buy
↔ Maintain
Argus Research
2025-12-11
Hold
(from Buy)
▼ Downgrade
Profitability
Gross Margin
60.06%TTM
Op. Margin
20.92%TTM
ROE
363.58%TTM
Rev. Growth
8.40%YoY
Free Cash Flow
3.32BTTM
FCF Yield
—TTM
Balance Sheet
Debt / Equity
1640.54MRQ
Current Ratio
1.02MRQ
Cash
1.42BMRQ
Total Debt
7.97BMRQ
Net Debt
—MRQ
Income
Div. Yield
2.24%TTM
Annual Rate
2.12Fwd
Payout Ratio
80.62%TTM
Dividend History
Payout Ratio (TTM): 80.62%
| Date | Amount / Share | Yield at Payment |
|---|---|---|
| 2026-07-20 | $0.5300 | 0.58% |
| 2026-04-20 | $0.5300 | 0.64% |
| 2026-01-21 | $0.5200 | 0.62% |
| 2025-10-17 | $0.5200 | 0.67% |
| 2025-07-18 | $0.5200 | 0.61% |
| 2025-04-17 | $0.5200 | 0.56% |
| 2025-01-21 | $0.5000 | 0.59% |
| 2024-10-18 | $0.5000 | 0.52% |
| 2024-07-19 | $0.5000 | 0.53% |
| 2024-04-19 | $0.5000 | 0.60% |
| 2024-01-19 | $0.4800 | 0.63% |
| 2023-10-20 | $0.4800 | 0.70% |
| 2023-07-20 | $0.4800 | 0.67% |
| 2023-04-20 | $0.4800 | 0.68% |
| 2023-01-20 | $0.4700 | 0.68% |
| 2022-10-20 | $0.4700 | 0.73% |
| 2022-07-20 | $0.4700 | 0.68% |
| 2022-04-20 | $0.4700 | 0.64% |
| 2022-01-21 | $0.4500 | 0.60% |
| 2021-10-20 | $0.4500 | 0.67% |
| 2021-07-20 | $0.4500 | 0.61% |
| 2021-04-20 | $0.4500 | 0.63% |
| 2021-01-22 | $0.4400 | 0.64% |
| 2020-10-22 | $0.4400 | 0.64% |
| 2020-07-17 | $0.4400 | 0.67% |
| 2020-04-17 | $0.4400 | 0.69% |
| 2020-01-22 | $0.4300 | 0.71% |
| 2019-10-22 | $0.4300 | 0.75% |
| 2019-07-17 | $0.4300 | 0.69% |
| 2019-04-17 | $0.4300 | 0.74% |
| 2019-01-22 | $0.4200 | 0.81% |
| 2018-10-18 | $0.4200 | 0.81% |
| 2018-07-17 | $0.4200 | 0.78% |
| 2018-04-19 | $0.4200 | 0.73% |
| 2018-01-22 | $0.4000 | 0.63% |
| 2017-10-20 | $0.4000 | 0.68% |
| 2017-07-14 | $0.4000 | 0.68% |
| 2017-04-19 | $0.4000 | 0.68% |
| 2017-01-19 | $0.3900 | 0.73% |
| 2016-10-20 | $0.3900 | 0.69% |
How CL Makes Its Money
Cash Flow Breakdown
Quarterly Metrics
| Quarter | Revenue | Rev YoY | Gross Profit | Op. Income | Net Income | Net YoY | Gross % | Op % | Net % |
|---|
Full Key Statistics
Valuation
| Market Cap | N/A |
| Enterprise Value | 81.70B |
| Trailing P/E | 35.96 |
| Forward P/E | 23.07 |
| PEG Ratio (5yr) | 1.64 |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 516.52 |
| EV/Revenue | 3.93 |
| EV/EBITDA | 16.60 |
Share Statistics
| Avg Vol (3m) | 5.17M |
| Shares Outstanding | N/A |
| Float | 750.71M |
| % Held by Insiders | 0.14% |
| % Held by Institutions | 87.95% |
| Short Ratio | 3.19 |
| Short % of Float | 2.33% |
Profitability
| Gross Margin | 60.06% |
| Operating Margin (ttm) | 20.92% |
| Profit Margin | 10.04% |
| Return on Assets (ttm) | 16.10% |
| Return on Equity (ttm) | 363.58% |
Income Statement
| Revenue (ttm) | 20.80B |
| Revenue Growth (yoy) | 8.40% |
| Gross Profit (ttm) | 12.49B |
| EBITDA | 4.92B |
| Net Income (ttm) | 2.09B |
| Diluted EPS (ttm) | 2.60 |
| EPS Growth (yoy) | -5.90% |
Balance Sheet
| Total Cash (mrq) | 1.42B |
| Total Debt (mrq) | 7.97B |
| Debt / Equity (mrq) | 1640.54 |
| Current Ratio (mrq) | 1.02 |
| Book Value / Share | 0.18 |
| Operating CF (ttm) | 4.34B |
| Free Cash Flow (ttm) | 3.32B |
Trading & Dividends
| Beta (5Y) | 0.32 |
| 50-Day MA | 90.72 |
| 200-Day MA | 85.82 |
| Fwd Dividend Yield | 229.00% |
| Payout Ratio | 80.62% |
Ownership Breakdown
Institutional 87.95%
Insider 0.14%
Public 11.9%
Short Interest
2.33% of float
Low
Institutional 13F Holdings
Famous investors who disclosed a position in CL in their latest SEC 13F filing.
Loading…
Insider Transactions
| Date | Insider | Role | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-01 | NEWMAN BRIAN | Director | Stock Award(Grant) at price 89.45 per share. | 209 | $18,695 |
| 2026-07-01 | NORRINGTON LORRIE M | Director | Stock Award(Grant) at price 89.45 per share. | 293 | $26,209 |
| 2026-07-01 | BILBREY JOHN P. | Director | Stock Award(Grant) at price 89.45 per share. | 265 | $23,704 |
| 2026-05-15 | MALCOLM GREGORY | Officer | Sale at price 88.44 per share. | 2,300 | $203,412 |
| 2026-05-11 | EDWARDS LISA MARIE | Director | Stock Award(Grant) at price 0.00 per share. | 2,075 | — |
| 2026-05-11 | NEWMAN BRIAN | Director | Stock Award(Grant) at price 0.00 per share. | 2,075 | — |
| 2026-05-11 | HARRIS C. MARTIN M.D. | Director | Stock Award(Grant) at price 0.00 per share. | 1,556 | — |
| 2026-05-11 | NORRINGTON LORRIE M | Director | Stock Award(Grant) at price 0.00 per share. | 2,075 | — |
| 2026-05-11 | NELSON KIMBERLY A. | Director | Stock Award(Grant) at price 0.00 per share. | 2,075 | — |
| 2026-05-11 | BOERNER CHRISTOPHER S | Director | Stock Award(Grant) at price 0.00 per share. | 1,383 | — |
| 2026-05-11 | BILBREY JOHN P. | Director | Stock Award(Grant) at price 0.00 per share. | 2,075 | — |
| 2026-05-11 | CAHILL JOHN T | Director | Stock Award(Grant) at price 0.00 per share. | 2,075 | — |
| 2026-05-11 | HUND-MEJEAN MARTINA | Director | Stock Award(Grant) at price 0.00 per share. | 2,075 | — |
| 2026-05-07 | MASSEY SALLY | Officer | Sale at price 87.41 per share. | 8,599 | $751,633 |
| 2026-04-01 | NEWMAN BRIAN | Director | Stock Award(Grant) at price 89.05 per share. | 210 | $18,700 |
| 2026-04-01 | BILBREY JOHN P. | Director | Stock Award(Grant) at price 89.05 per share. | 266 | $23,687 |
| 2026-04-01 | NORRINGTON LORRIE M | Director | Stock Award(Grant) at price 89.05 per share. | 294 | $26,181 |
| 2026-02-23 | MASSEY SALLY | Officer | Stock Award(Grant) at price 0.00 per share. | 16,805 | — |
| 2026-02-23 | MALCOLM GREGORY | Officer | Stock Award(Grant) at price 0.00 per share. | 6,268 | — |
| 2026-02-23 | HAZLIN JOHN | Officer | Stock Award(Grant) at price 0.00 per share. | 12,803 | — |
| 2026-02-23 | TSOURAPAS PANAGIOTIS | Officer | Stock Award(Grant) at price 0.00 per share. | 25,742 | — |
| 2026-02-23 | SUTULA STANLEY J III | Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | 38,678 | — |
| 2026-02-23 | WALLACE NOEL R | Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | 136,710 | — |
| 2026-02-23 | DANIELS JENNIFER M. | Officer | Stock Award(Grant) at price 0.00 per share. | 25,742 | — |
| 2026-02-12 | TSOURAPAS PANAGIOTIS | Officer | Sale at price 94.61 - 97.81 per share. | 50,000 | $4,778,436 |
NEWMAN BRIAN
Director
Stock Award(Grant) at price 89.45 per share.
2026-07-01
209 sh
$18,695
NORRINGTON LORRIE M
Director
Stock Award(Grant) at price 89.45 per share.
2026-07-01
293 sh
$26,209
BILBREY JOHN P.
Director
Stock Award(Grant) at price 89.45 per share.
2026-07-01
265 sh
$23,704
MALCOLM GREGORY
Officer
Sale at price 88.44 per share.
2026-05-15
2,300 sh
$203,412
EDWARDS LISA MARIE
Director
Stock Award(Grant) at price 0.00 per share.
2026-05-11
2,075 sh
—
NEWMAN BRIAN
Director
Stock Award(Grant) at price 0.00 per share.
2026-05-11
2,075 sh
—
HARRIS C. MARTIN M.D.
Director
Stock Award(Grant) at price 0.00 per share.
2026-05-11
1,556 sh
—
NORRINGTON LORRIE M
Director
Stock Award(Grant) at price 0.00 per share.
2026-05-11
2,075 sh
—
NELSON KIMBERLY A.
Director
Stock Award(Grant) at price 0.00 per share.
2026-05-11
2,075 sh
—
BOERNER CHRISTOPHER S
Director
Stock Award(Grant) at price 0.00 per share.
2026-05-11
1,383 sh
—
BILBREY JOHN P.
Director
Stock Award(Grant) at price 0.00 per share.
2026-05-11
2,075 sh
—
CAHILL JOHN T
Director
Stock Award(Grant) at price 0.00 per share.
2026-05-11
2,075 sh
—
HUND-MEJEAN MARTINA
Director
Stock Award(Grant) at price 0.00 per share.
2026-05-11
2,075 sh
—
MASSEY SALLY
Officer
Sale at price 87.41 per share.
2026-05-07
8,599 sh
$751,633
NEWMAN BRIAN
Director
Stock Award(Grant) at price 89.05 per share.
2026-04-01
210 sh
$18,700
BILBREY JOHN P.
Director
Stock Award(Grant) at price 89.05 per share.
2026-04-01
266 sh
$23,687
NORRINGTON LORRIE M
Director
Stock Award(Grant) at price 89.05 per share.
2026-04-01
294 sh
$26,181
MASSEY SALLY
Officer
Stock Award(Grant) at price 0.00 per share.
2026-02-23
16,805 sh
—
MALCOLM GREGORY
Officer
Stock Award(Grant) at price 0.00 per share.
2026-02-23
6,268 sh
—
HAZLIN JOHN
Officer
Stock Award(Grant) at price 0.00 per share.
2026-02-23
12,803 sh
—
TSOURAPAS PANAGIOTIS
Officer
Stock Award(Grant) at price 0.00 per share.
2026-02-23
25,742 sh
—
SUTULA STANLEY J III
Chief Financial Officer
Stock Award(Grant) at price 0.00 per share.
2026-02-23
38,678 sh
—
WALLACE NOEL R
Chief Executive Officer
Stock Award(Grant) at price 0.00 per share.
2026-02-23
136,710 sh
—
DANIELS JENNIFER M.
Officer
Stock Award(Grant) at price 0.00 per share.
2026-02-23
25,742 sh
—
TSOURAPAS PANAGIOTIS
Officer
Sale at price 94.61 - 97.81 per share.
2026-02-12
50,000 sh
$4,778,436